{"brief_title": "Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7", "brief_summary": "The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.", "condition": ["Opioid-Related Disorders", "Substance-Related Disorders"], "intervention_type": ["Drug"], "intervention_name": ["Lofexidine"], "criteria": "Please contact site for information.", "gender": "All", "minimum_age": "21 Years", "maximum_age": "59 Years", "healthy_volunteers": "No", "mesh_term": ["Disease", "Opioid-Related Disorders", "Substance-Related Disorders", "Lofexidine", "Clonidine"], "id": "NCT00000358"}